TSVC

VC Los Altos, United States · Founded 2010

TSVC is a Silicon Valley seed-stage venture firm focused on backing exceptional technical founders at the earliest stages of company building, with a strong emphasis on deep tech, physical AI, and advanced scientific innovations.

About TSVC

TSVC, based in Silicon Valley with a presence at tsvcap.com and an active Crunchbase profile, is an early-stage venture firm best known for backing seed companies that have gone on to become category leaders, including notable consumer and enterprise outcomes. The input does not specify a healthcare mandate, and TSVC is broadly understood as a generalist seed investor rather than a healthcare specialist. For founders, the practical read is that healthcare AI deals will be considered on the merits of team and traction rather than as part of a programmatic vertical strategy. The fund typically writes seed tickets in the high six- to low seven-figure USD range and frequently follows on, which means it can lead or co-lead a true seed round. Healthcare AI founders building software-defined products with consumer-grade UX, enterprise SaaS targeting providers or payers, or AI infrastructure usable in regulated environments are the most natural candidates. Drug discovery platforms, regulated devices needing PMA pathways, and capital-intensive therapeutic plays will not match the firm’s risk profile. Geographic preference skews to the Bay Area and US-anchored teams, though TSVC has backed cross-border founders. Best entry path is a warm introduction through a TSVC portfolio CEO; cold outreach via LinkedIn or the website tends to be lower-yield given the firm’s deal flow. When you do reach a partner, lead with traction, a one-line market wedge, and a clear ask on round size, lead status, and timing rather than a long product narrative.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by TSVC

Tools made by companies in TSVC's portfolio that we cover in the directory.

WellDoc BlueStar
WellDoc
Cardiology AI
WellDoc BlueStar is an FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.
AiCure (H. Code)
AiCure
Drug Discovery & Research
AiCure's H.Code is an AI-powered platform using computer vision and predictive analytics to verify and improve medication and clinical behavior adherence in clinical trials and healthcare settings.

Portfolio companies in our directory

Other portfolio companies

Companies in TSVC's portfolio not currently in our directory.

Team

Eugene Zhang
Founding Partner
Chun Xia
Founding Partner
Charles Shao
General Partner
Spencer Greene
General Partner
Lisheng Wang
General Partner

Pitch / review this investor

Have you raised from TSVC? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.